Metraipolis › archive › dc_4959ead34c28

Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database — Europe PMC PMID:40144657

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40144657
DOI
10.3389/fphar.2025.1521358
License (as archived)
solo-consultazione
Archived
2026-10-07T21:54:31.820Z
SHA-256 of the archived text
893d57a2acd1ea204917a58632e5b18a1131fec9eb14fa5c655ad063bf46f7dc
Stable URL of this page
https://metraipolis.com/documento/dc_4959ead34c28

How to cite

Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database — Europe PMC PMID:40144657 — Europe PMC (en), https://europepmc.org/article/MED/40144657 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4959ead34c28 (Metraipolis archive dc_4959ead34c28, sha256 893d57a2acd1ea204917a58632e5b18a1131fec9eb14fa5c655ad063bf46f7dc)
BibTeX
@misc{dc4959ead34c28,
  title = {Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database — Europe PMC PMID:40144657},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40144657},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4959ead34c28; sha256 893d57a2acd1ea204917a58632e5b18a1131fec9eb14fa5c655ad063bf46f7dc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40144657. Agents can read the archived copy with the MCP tool read_document.